Shire, Barr Resolve Suits Over Generic Adderall
Shire PLC and Barr Pharmaceuticals have made amends in a long-running patent stand-off over Barr's efforts to market a copycat version of Shire's blockbuster hyperactivity drug Adderall....To view the full article, register now.
Already a subscriber? Click here to view full article